If you're looking for value, income and safety, here's why you should turn your allegiance to the Dividend Aristocrats. Read More
JNJ
Filter
The first quarter was the best in a decade, as all S&P 500 sectors registered gains. Let's take a look at Q1 performance, sector by sector. Read More
As the largest health insurer in the U.S., UnitedHealth Group is poised to greatly benefit from booming health care expenditures. But do proposed government policy changes threaten the stock? Read More
Health services giant Johnson & Johnson has been a reliable growth-and-income stock for years, but can it overcome the scandal about its allegedly carcinogenic talcum powder? Read More
Is Geron a small-cap stock poised to breakout? Or will this clinical stage biotech run out of cash before its novel drugs can hit the market? Read More
Shares of healthcare conglomerate Johnson & Johnson (NYSE: JNJ) plunged 10% on December 14 in response to an investigative news story by Reuters that accused the company of covering up the use of asbestos in its popular baby powder product: “From at least 1971 to the early 2000s,… Read More